Goeckerman regimen for management of psoriasis refractory to biologic therapy: the University of California San Francisco experience. 2013

Sarah Fitzmaurice, and Tina Bhutani, and John Koo
University of California Davis School of Medicine, Davis, California.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D003033 Coal Tar A by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985) (Merck Index, 11th ed). Clinitar,Estar,Tar, Coal
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Sarah Fitzmaurice, and Tina Bhutani, and John Koo
July 2014, Journal of the American Academy of Dermatology,
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
February 2009, Journal of the American Academy of Dermatology,
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
March 1989, Archives of otolaryngology--head & neck surgery,
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
August 1995, Archives of surgery (Chicago, Ill. : 1960),
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
January 2000, Journal of pediatric hematology/oncology,
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
November 2004, The Journal of urology,
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
April 1978, The British journal of dermatology,
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
October 1987, Cancer,
Sarah Fitzmaurice, and Tina Bhutani, and John Koo
January 2003, Alternative therapies in health and medicine,
Copied contents to your clipboard!